Clinical Trials Browser

OTHER_GOV × Uterine Cervical Neoplasms × 30 days × Clear all

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT07435623 2026-03-02

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03005743 2026-02-23

COMBAT-Cx

Phase NA Completed

Uterine Cervical Neoplasms

NCT05102240 2026-02-20

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Uterine Cervical Neoplasms

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Phase NA Recruiting

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT03997110 2026-02-17

RAPPAL

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT07400809 2026-02-17

Retro-COSMOS

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence